LQFM020

LQFM020 is an orally active pyrazole derivative. LQFM020 inhibits Ca+ and activates K+ and NO/cGMP channels to inhibit vasoconstriction. LQFM020 has anti-inflammatory and anti-analgesic activities[1].

Product Specifications

CAS Number

[1431459-41-4]

UNSPSC

12352005

Target

Calcium Channel; Potassium Channel

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Field of Research

Inflammation/Immunology

Smiles

FC1=CC=C(N2N=CC(C3=NN=NN3)=C2)C=C1

Molecular Formula

C10H7FN6

Molecular Weight

230.20

References & Citations

[1]de Oliveira, et al. 2017. “New Pyrazole Derivative 5-[1- (4-Fluorophenyl) -1H-pyrazol-4-yl]-2H-tetrazole: Synthesis and Assessment of Some Biological Activities.” Chemical Biology & Drug Design 89, no. 1: 124–135.